Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

IPOF Stock: What Is Going on With Chamath Palihapitiya’s SPAC Today?

Here's what investors may want to know about the various rumors surrounding the potential merger partner for IPOF stock right now.

7 Cathie Wood Stocks Every Growth Investor Needs In Their Portfolio

These top seven stocks among Cathie Wood's top holdings are ones investors may be enticed to consider right now.

ALF Stock: What Is Going on With Retail Favorite Alfi Today?

Today, investors in Alfi and ALF stock are seeing impressive momentum to the upside, as investors pile into this growth stock.

NVAX Stock: 2 Big Reasons Novavax Is Sliding Lower Today

Today, investors in Novavax are seeing a lot of red due to a key catalyst that's taking NVAX stock significantly lower.

Why SNOA Stock Is Getting a Bezos-Sized Boost Today

Today, investors in Sonoma Pharmaceuticals and SNOA stock are seeing impressive gains as the company launches its products on Amazon.